HOME / ¹®¼­°øÀ¯ / /

Èıâ1°Ç
Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ - ½æ³×ÀÏ 1page
1/55
  • 1 page
  • 2 page
  • 3 page
  • 4 page
  • 5 page
  • 6 page
  • 7 page
  • 8 page
  • 9 page
  • 10 page
  • 11 page
  • 12 page
  • 13 page
  • 14 page
  • 15 page
  • 16 page
  • 17 page
  • 18 page
  • 19 page
  • 20 page
  • 21 page
  • 22 page
  • 23 page
  • 24 page
  • 25 page
  • 26 page
  • 27 page
  • 28 page
  • 29 page
  • 30 page
  • 31 page
  • 32 page
  • 33 page
  • 34 page
  • 35 page
  • 36 page
  • 37 page
  • 38 page
  • 39 page
  • 40 page
  • 41 page
  • 42 page
  • 43 page
  • 44 page
  • 45 page
  • 46 page
  • 47 page
  • 48 page
  • 49 page
  • 50 page
  • 51 page
  • 52 page
  • 53 page
  • 54 page
  • 55 page

Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­

¼­½Ä¹øÈ£
TZ-SHR-49735
µî·ÏÀÏÀÚ
2012.05.17
ºÐ·®
55 page / 366.0 KB
Æ÷ÀÎÆ®
¹«·á ¹®¼­°øÀ¯ Æ÷ÀÎÆ® Àû¸³¹æ¹ý ¾È³»
ÆÄÀÏ Æ÷¸Ë
Microsoft PowerPoint (ppt)
Èıâ Æò°¡

5.0

1°ÇÀÇ Èı⺸±â

µî·ÏÀÚ

ly*** ½Ç¹ö

µî±Þº° ÇýÅú¸±â

±¹Á¦Çмú´ëȸ ¹ßÇ¥µÈ Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡º¸°í¼­ Âü°íÀÚ·áÀÔ´Ï´Ù.

  • Microsoft PowerPoint (ppt)Microsoft PowerPoint (ppt)
º´¿øÀ§¿øȸÀ§¿øȸº¸°í¼­º´¿øÇÁ·Î±×·¥Æò°¡º¸°í¼­ºñ±³º¸°í¼­°ËÁøÇÁ·Î±×·¥Æ¯º°À§¿øȸ
¿¬°ü ÃßõÀÚ·á
 Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #1    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #2    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #3
 Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #4    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #5    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #6
 Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #7    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #8    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #9
 Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #10    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #11    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #12
 Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #13    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #14    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #15
 Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #16    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #17    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #18
 Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #19    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #20    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #21
 Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #22    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #23    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #24
 Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #25    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #26    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #27
 Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #28    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #29    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #30
 Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #31    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #32    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #33
 Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #34    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #35    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #36
 Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #37    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #38    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #39
 Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #40    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #41    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #42
 Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #43    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #44    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #45
 Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #46    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #47    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #48
 Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #49    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #50    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #51
 Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #52    Á¾ÇÕº´¿ø °ËÁø ÇÁ·Î±×·¥°ú ¹ÌÁúº´¿¹¹æ À§¿øȸÀÇ ±Ç°í¾È Æò°¡ ºñ±³º¸°í¼­ #53  
º» ¹®¼­ÀÇ ºÐ·® : 55 ÆäÀÌÁö

1Àå Challenges for prevention

2Àå Evidence-based medicine

3Àå Why be strict when evidence is insufficient?

4Àå Where US medicine fails EBM

5Àå The U.S. Preventive Services Task Force

6Àå Steps in explicit process (USPSTF)

7Àå Evidence grading

8Àå Analytic framework

9Àå Analytic framework for screening for a disease


10Àå Grades of Recommendation

11Àå Wording of recommendations

12Àå The I letter grade

13Àå Reasons for conflicting recommendations

14Àå Conflicting guidelines

15Àå Other areas of uncertainty

16Àå Summary of task force method

17Àå Differences from USPSTF

18Àå Stomach cancer

19Àå Liver cancer

20Àå Multiphasic testing

21Àå Urine testing

22Àå Tumor marker testing

23Àå Imaging screening

24Àå Miscellaneous screening

25Àå Risks of screening (examples)

26Àå Conclusions

     
evaluating the nhic screening program, the general hospital health program, and the us preventive services task force recommendations: what does the evidence support?

ned calonge, m. d

, m. p

h. colorado chief medical officer  chair, uspstf  
°Ç°­º¸Çè°ø´Ü°ú Á¾ÇÕº´¿øÀÇ °Ç°­°ËÁøÇÁ·Î±×·¥ ¹×
¹Ì Áúº´¿¹¹æƯº°À§¿øȸ ±Ç°í¾È°úÀÇ ºñ±³ Æò°¡ :  
±× °á°ú, ¿ì¸®´Â ¹«¾ùÀ» ¾Ë ¼ö Àִ°¡?
  objectives(°­ÀÇ ³»¿ë)  discuss(³íÀÇ)  
us preventive services task force structure, methods and recommendations
(¹Ì Áúº´¿¹¹æƯº°À§¿øȸÀÇ ±¸Á¶, ¹æ¹ý·Ð ¹× ±Ç°í»çÇ×)
evaluation of nhic screening program  (±¹¹Î°Ç°­º¸Çè°ø´ÜÀÇ °Ç°­°ËÁø ÇÁ·Î±×·¥ Æò°¡)  evaluation of general hospital health program  (ÀÏ¹Ý Á¾ÇÕº´¿øÀÇ °Ç°­°ËÁø ÇÁ·Î±×·¥ Æò°¡)    challenges for prevention  (¿¹¹æ»ç¾÷ÀÌ Á÷¸éÇÑ °úÁ¦)  not everything that might work does work  (¸ðµç °ÍÀÌ ´Ù ÀǵµµÈ °á°ú¸¦ °¡Á®¿ÀÁö´Â ¾ÊÀ½)  
services should be supported by good evidence before they are widely recommended
(¿¹¹æ»ç¾÷Àº ³Î¸® ±Ç°íµÇ±â ÀÌÀü¿¡ ÃæºÐÇÑ ±Ù°Å¿¡ ÀÇÇØ µÞ¹Þħ µÇ¾î¾ß ÇÔ)
there are harms associated with screening that must be weighed against potential benefit, especially if benefit is unproven
(ƯÈ÷, °ËÁø½Ç½ÃÀÇ À¯ÀÍÇÔÀÌ ÀÔÁõµÇÁö ¾Ê´Â °æ¿ì¿¡´Â, ¹Ýµå½Ã °ËÁø¿¡ µû¸¥ ÀÌÀÍ°ú ÇؾÇÀÌ ºñ±³ °ËÅäµÈ ÈÄ °ËÁøÀ» ½Ç½Ã ÇÏ¿©¾ß ÇÔ)
  evidence-based medicine  (°úÇÐÀû Áõ°Å¿¡ ±âÃÊÇÑ ÀÇ·á)  
base decisions on evidence of effectiveness and benefit
(ÀÔÁõµÈ È¿°ú¼º°ú À¯ÀÍÇÔÀ» ±âÃÊ·Î ÇÏ¿© °áÁ¤À» ³»·Á¶ó)
when there is evidence of benefit, do it  (À¯ÀÍÇÔÀÌ ÀÖ´Ù´Â Áõ°Å°¡ ÀÖÀ¸¸é ½ÃÇàÇ϶ó)  
when there is evidence of no benefit or harm, don¡¯t do it
(À̷οî Á¡ÀÌ ¾ø°Å³ª, Çطοî Á¡ÀÌ ÀÖ´Ù´Â Áõ°Å°¡ ÀÖÀ¸¸é ½ÃÇàÇÏÁö ¸»¾Æ¶ó)
when there is insufficient evidence to determine if there is benefit, be conservative: use individual discretion, but if there are harms or costs, don¡¯t do it
(ÀÌÁ¡ÀÌ ÀÖ´ÂÁö ¾ø´ÂÁö °áÁ¤ÇÒ ¼ö ÀÖ´Â Áõ°Å°¡ ÃæºÐÄ¡ ¾ÊÀ¸¸é, ½ÅÁßÇ϶ó : Àç·®À» ¹ßÈÖÇϵÇ, ÇØ°¡ Àְųª ºñ¿ëÀÌ ¸¹ÀÌ µé¸é ½ÃÇàÇÏÁö ¸»¾Æ¶ó)
  
why be strict when evidence is insufficient?
(ºÒÃæºÐÇÑ Áõ°Å ¼ö¿ë¿¡ µÚµû¸£´Â À§Ç輺)     (ÀÌÇÏ »ý·«)

¹ÞÀº º°Á¡

5.0/5

1°³ÀÇ º°Á¡

¹®¼­°øÀ¯ ÀڷḦ µî·ÏÇØ ÁÖ¼¼¿ä.
¹®¼­°øÀ¯ Æ÷ÀÎÆ®¿Í Çö±ÝÀ» µå¸³´Ï´Ù.

Æ÷ÀÎÆ® : ÀÚ·á 1°Ç´ç ÃÖ´ë 5,000P Áö±Þ

Çö±Ý : ÀÚ·á 1°Ç´ç ÃÖ´ë 2,000¿ø Áö±Þ

ÈıâÀÛ¼º»ç¿ëÈı⸦ ÀÛ¼ºÇÏ½Ã¸é ¹®¼­°øÀ¯ 100 point¸¦ Àû¸³ÇØ µå¸³´Ï´Ù.

¼­½Äº°Á¡ ¡Ù¡Ù¡Ù¡Ù¡Ù

0/120

»ç¿ëÈıâ (1)

  • 2013-07-17hi****

    ÀÚ·áÀÇ ¿Ï¼ºµµ°¡ ¸Å¿ì ³ô³×¿ä. ¾÷¹«¿¡ ´Ù¾çÇÑ Àû¿ë¼º°ú ¾ÆÀ̵ð¾î¸¦ ¾ò´Âµ¥ Å« µµ¿òÀÌ µÇ¾ú½À´Ï´Ù.

ÀÌÀü1´ÙÀ½